Skin Care :: Wrinkles and Alpha Hydroxy Acid n Home Exfoliation

One of the basic methods for improving skin and eliminating small wrinkles is exfoliation (also called resurfacing), which is the removal of the top layer of skin to allow regrowth for new skin. Methods for doing this run from simple scrubs to special creams to intensive peeling treatments, including laser resurfacing. [See What Are Professional Resurfacing Procedures for Skin Wrinkles?] People with darker skin are at particularly higher risk for scarring or discoloration with the more powerful exfoliation methods.

Heart Disease :: Protein and unsaturated fat may enhance heart health benefits

The types of food eaten in an effort to cut down on saturated fat may make a difference in reducing heart disease risk, according to a study of people with either high blood pressure or prehypertension. The study was supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.

Glycogen Storage Disease :: Glycogen Storage Disease Type 0 n Homeopathy

Type 0 glycogen storage disease (GSD 0) is caused by a deficiency in glycogen synthase, an enzyme critical for adequate glycogen synthesis. As a result, there is a marked decrease in glycogen stores resulting in fasting hypoglycemia and post-prandial hyperglycemia. Dietary carbohydrates are preferentially converted to lactate.

Prostate Cancer :: Detection of Early Prostate Cancer

A new study, using a unique detection method, has led scientists to identify several genes whose rearrangements in prostate cancer cells may play a role in the development and progression of the disease. Researchers at the University of Michigan, Ann Arbor, report that two genes, ETV1 and ERG, which previously were implicated as cancer-causing gene rearrangements in Ewing’s sarcoma (a relatively rare bone cancer), are now seen as important cancer-causing genes in prostate cancer. Closer analysis showed how rearrangement of these genes was responsible for their cancer-causing potential. The research appears in the October 28, 2005, issue of Science and was supported by the National Cancer Institute (NCI), part of the National Institutes of Health.

Leukemia :: Arranon for Rare Leukemia and Lymphoma

The Food and Drug Administration (FDA) announced the approval of Arranon (nelarabine) for marketing in the United States. This is a new drug to treat adults and children with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), whose disease has not responded to or has relapsed following at least two chemotherapy regimens. Arranon is the first drug to treat this limited population of patients.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack